Adetifa IMO
Uyoga S
Gitonga JN
Mugo D
Otiende M
Nyagwange J
Karanja HK
Tuju J
Wanjiku P
Aman R
Mwangangi M
Amoth P
Kasera K
Ng'ang'a W
Rombo C
Yegon C
Kithi K
Odhiambo E
Rotich T
Orgut I
Kihara S
Bottomley C
Kagucia EW
Gallagher KE
Etyang A
Voller S
Lambe T
Wright D
Barasa E
Tsofa B
Bejon P
Ochola-Oyier LI
Agweyu A
Scott JAG
Warimwe GM
Nat Commun. 2021;123966
Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with apparently low associated mortality.
